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Abstract White matter changes occur endemically in
routine magnetic resonance imaging (MRI) scans of elderly
persons. MRI appearance and histopathological correlates
of white matter changes are heterogeneous. Smooth peri-
ventricular hyperintensities, including caps around the
ventricular horns, periventricular lining and halos are likely
to be of non-vascular origin. They relate to a disruption of
the ependymal lining with subependymal widening of the
extracellular space and have to be differentiated from
subcortical and deep white matter abnormalities. For the
latter a distinction needs to be made between punctate,
early confluent and confluent types. Although punctate
white matter lesions often represent widened perivascular
spaces without substantial ischemic tissue damage, early
confluent and confluent lesions correspond to incomplete
ischemic destruction. Punctate abnormalities on MRI show
a low tendency for progression, while early confluent and
confluent changes progress rapidly. The causative and
modifying pathways involved in the occurrence of sporadic
age-related white matter changes are still incompletely
understood, but recent microarray and genome-wide asso-
ciation approaches increased the notion of pathways that
might be considered as targets for therapeutic intervention.
The majority of differentially regulated transcripts in white
matter lesions encode genes associated with immune
function, cell cycle, proteolysis, and ion transport. Gen-
ome-wide association studies identified six SNPs mapping
to a locus on chromosome 17q25 to be related to white
matter lesion load in the general population. We also report
first and preliminary data that demonstrate apolipopro-
tein E (ApoE) immunoreactivity in white matter lesions
and support epidemiological findings indicating that ApoE
is another factor possibly related to white matter lesion
occurrence. Further insights come from modern MRI tech-
niques, such as diffusion tensor and magnetization transfer
imaging, as they provide tools for the characterization of
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normal-appearing brain tissue beyond what can be expected
from standard MRI scans. There is a need for additional pre-
and postmortem studies in humans, including these new
imaging techniques.
Keywords White matter lesions  Leukoaraiosis 
White matter change  MRI
Introduction
Incidental white matter changes are a common finding on
magnetic resonance imaging (MRI) of the brain. They
relate to advancing age and always occur on the basis of
specific pathological and biological processes. Different
terms such as, white matter lesions, white matter hyperin-
tensities or leukoaraiosis are interchangeably used to define
these abnormalities. Hachinski [33] introduced the term
leukoaraiosis (from the Greek leuko [white] and araiosis
[rarefaction]) to designate both periventricular or subcor-
tical (centrum semiovale) areas of hypodensity on CT or
hyperintensity on T2-weighted MRI. It is of note that the
term leukoaraiosis refers to both the CT- and MRI-
detectable alterations, although the lesions are not com-
pletely superimposable as to number, site and extension
[54]. This review will focus on the heterogeneity of age-
related white matter changes regarding their MRI appear-
ance, clinical consequences, rate of progression and
pathohistological correlates.
White matter changes on in vivo and ex vivo MRI
MRI classifications of white matter changes usually sepa-
rate (a) periventricular and (b) deep/subcortical signal
abnormalities [45]. Periventricular changes typically
include caps around the frontal horns of the lateral ven-
tricles and pencil-thin lining or a smooth halo along the
side of the lateral ventricles. Deep/subcortical signal
changes can occur as punctate changes or beginning con-
fluent or confluent abnormalities [18] (Fig. 1). Numerous
studies examined the histopathological correlates of age-
related white matter changes using postmortem MRIs as
the references [2, 3, 10, 11, 15, 17, 20, 21, 23, 24, 30, 46,
50, 58, 59, 63, 77–80, 91, 95]. It is important to realize that
fixation, but also autolysis, and changes in temperature
may significantly change relaxation times, water content,
and tissue structure, which may significantly impact on the
reliability of postmortem MRI for white matter lesion
detection. The most significant changes typically come
Fig. 1 White matter changes in T2-weighted FLAIR MRI scans. The first column shows periventricular white matter changes: a caps, b pencil-
thin lining and c halo. The second column shows deep or subcortical white matter changes: d punctate, e early confluent, and f confluent lesions
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from the fixation process, which dehydrates the tissue and
consequently shortens all relaxation times, T2 much more
than T1. The relaxation times are usually stabilized after
approximately 3–4 weeks of fixation [55, 75]. Early
studies claimed that postmortem MRI reliably detects
white matter lesions with some problems occurring with
small punctate foci [20]. Fernando et al. [23] compared
postmortem MRI of white matter lesions in fixed brain
slices with pathology in 33 brains and described that MRI
detection of lesions was less sensitive than pathology. A
sensitivity of 95% and a specificity of 71% were reported
for periventricular abnormalities, for deep/subcortical
white matter changes the sensitivity was 86% and the
specificity was 80%. In general, postmortem MRI of
formalin-fixed brain slices was considered a reliable
method to obtain data on both the severity and also dis-
tribution of white matter changes.
Frequency of age-related white matter changes
In population-based studies, the prevalence of any white
matter lesions varies between 45 and 95%. Depending on the
composition of the investigated cohorts, 12–33% of subjects
have severe abnormalities [89]. Table 1 displays the fre-
quency of the different types of MRI white matter lesions in
the community-dwelling Austrian Stroke Prevention Study
[67]. Caps/lining and punctate deep/subcortical white matter
lesions are by far the most common signal changes in elderly
subjects and occur in more than half of asymptomatic persons
even in age groups below 55 years. All other white matter
abnormalities are substantially less frequent, but their fre-
quency increases with age, and in subjects above 75 years
they affect at least one-fifth of individuals free of any overt
signs of neurologic disease. In symptomatic patients, the fre-
quency of white matter abnormalities is often higher. This is
particularly seen in dementia where periventricular changes
have been reported in all patients irrespective of the dementia
type, and deep/subcortical lesions occurred in 85% of patients
with Lewy body dementia, 89% with Alzheimer’s disease,
and 96% with vascular dementia [5].
Risk factors and key clinical findings
The heterogeneous appearance of white matter changes on
MRI implies differences in risk factors and clinical con-
sequences. The Leukoaraiosis and Disability (LADIS)
Study provides evidence for such differences. The study
investigated risk factor profile effects on heterogeneous
white matter lesion types and is the only study that sys-
tematically compared equally sized groups of individuals
with punctate, early confluent, and confluent white matter
changes [53]. Individuals with coalescent white matter
lesions were significantly older and more frequently had
hypertension and a history of stroke as compared to sub-
jects with punctate abnormalities. The amount of cigarettes
smoked, and the interaction between hypercholesterolemia
and smoking were associated with confluent white matter
changes only [6]. Consequences on cognitive function
represent a key clinical finding related to age-related white
matter changes. White matter lesions affect executive
function often severely enough to impair activities of daily
life resulting from erroneous goal formation, planning, and
organization [39–41, 57]. Abstract reasoning is also com-
monly affected, but patients only suffer from mild memory
deficits [38] with slight recognition and cueing difficulties
[16]. Motor disturbances affect gait, postural control, and
urinary continence [4, 35, 36, 56]. There exists a large
inter-individual variability of the clinical presentation in
subjects with white matter changes. Clinical consequences
are likely to be influenced by lesion distribution in strate-
gically relevant brain regions and by volume. Nonetheless,
different lesion types have different clinical impact. LADIS
consistently demonstrated significant differences between
the performance of patients with punctate changes when
compared with those with early confluent and confluent
changes with the latter always being most impaired. Such
Table 1 Prevalence of different types of white matter changes in 993 participants (age range 45–87 years) from the Austrian Stroke Prevention
Study
Age (years) Periventricular white matter lesionsa Deep/subcortical white matter lesionsa
Caps/lining
(N = 632)
Halo (N = 61) Punctate
(N = 586)
Early confluent
(N = 150)
Confluent
(N = 76)
N (%) N (%) N (%) N (%) N (%)
\55 (N = 128) 66 (51.5) 0 (0) 76 (59.3) 3 (2.3) 0 (0)
55–64 (N = 344) 203 (59.0) 5 (1.4) 236 (68.6) 17 (4.9) 9 (2.6)
65–74 (N = 374) 254 (67.9) 27 (7.2) 209 (55.8) 88 (23.5) 32 (8.5)
C75 (N = 147) 109 (74.1) 29 (19.7) 65 (44.2) 42 (28.5) 35 (23.5)
a Several individuals had more than one lesion type
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relationships were seen for all clinical correlates, including
cognition [87], depression [86], gait and balance [4], as
well as urinary incontinence [56]. Most importantly, early
confluent and to a greater extent confluent white matter
abnormalities predicted functional decline in activities of
daily living during a relatively short observational period
of 3 years [37].
Progression of white matter changes
White matter lesion heterogeneity is not only reflected by
differences in clinical consequences, but also by the rate of
lesion progression. All investigations agree that the extent
of lesions at baseline is a major predictor of subsequent
progression [62, 65, 85, 90].
In the Austrian Stroke Prevention Study [65], there was
almost no increase in lesion volume in subjects with
punctate abnormalities, whereas participants with a base-
line finding of early confluent or confluent changes showed
a remarkably more rapid increase in lesion volume. After 3
and 6 years of follow-up, subjects with confluent white
matter abnormalities at baseline experienced a 5 and
13 cm3 increase in lesion volume, respectively. Figure 2
shows examples of different lesion progression depending
on the baseline lesion grade.
Table 2 demonstrates the frequency of progression of
the various white matter lesion types in our own commu-
nity-based cohort (unpublished data). The lowest rate of
progression is seen for punctate abnormalities, while the
majority of subjects with early confluent and almost all
subjects with confluent white matter lesions show pro-
gression. These data together with the pathological findings
support the view that punctate white matter lesions are of
mixed origin and relatively benign, whereas early confluent
and confluent white matter abnormalities are ischemic,
progressive, and thus malignant [68]. According to our
data, smooth periventricular halos also show a considerable
tendency to progress even though they are assumed to be of
non-ischemic origin [21]. The reason for the relatively high
progression rate of this lesion type might be seen in its
association with ventricular enlargement which in the
elderly is known to increase over time and probably leads
to enhanced disruption of the ventricular ependymal lining
with subsequent leakage of cerebrospinal fluid into the
periventricular white matter [19].
Fig. 2 Flair images of three clinically normal subjects at baseline and
3-year follow-up. Upper row gives examples of punctate (a), early
confluent (b) and confluent (c) white matter lesions. At follow-up,
lesion progression is noted depending on the baseline grade (arrows).
It is absent or only minimal as in the displayed case with punctate (d),
moderately severe in subjects with early confluent and confluent
abnormalities (e, f)
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Neuropathologic correlates of different types
of age-related white matter changes
In general, white matter lesions have been described to
reflect partial loss of myelin, axons, and astrogliosis in the
vicinity of small vessel changes. Tissue changes are
thought to relate to incomplete infarction, although small
deep white matter infarcts have also been described [28].
Importantly, only few histopathologic correlative investi-
gations accounted for the heterogeneity of MRI-detected
white matter changes. Typical examples of MRI to histo-
pathology correlations are displayed in Fig. 3.
Histopathological studies assessing the pathological
correlates of different white matter lesion types are sum-
marized in Table 3. As can be seen from this table, non-
ischemic and ischemic brain changes have been described.
Periventricular WMC
Smooth periventricular white matter hyperintensities
appear to be of non-vascular origin. The smooth caps
around the frontal horns were consistently found to corre-
spond to a spongiotic zone of finely textured myelin [15,
21] (Fig. 3a, b), and are considered to represent normal
anatomical structures in the fasciculus subcallosus. Some
authors suggest increased periventricular water content,
which converges from the surrounding white matter in this
area or comes from the intense venous network of this
region [21, 83]. Disruption of the ependymal lining of the
lateral ventricle and subependymal gliosis, so-called
ependymitis granularis, is another histologic finding almost
invariably noted with periventricular smooth caps. It is not
yet clear, if the ependymal alterations truly represent a
pathologic phenomenon and contribute to the occurrence of
periventricular changes [44, 83]. A significant correlation
between denudation of the ventricular lining and the extent
of periventricular hyperintensities is in favor of such a
mechanism [64]. Smooth periventricular caps extending
posteriorly along the body of the lateral ventricles is called
‘‘lining’’ or when broader ‘‘smooth halo’’ (Fig. 1c). The
tissue changes resemble those seen in the region of
hyperintense caps [21]. Frequently, the ependymal lining
of the ventricular walls is irregular or partly disrupted and a
rim of gliotic tissue borders the ventricular lumen. Next to
the ependymal and subependymal changes, there follows a
zone with markedly reduced or absent myelin staining.
Although myelin loss may be more pronounced around
veins, there is no evidence for associated arteriolosclerosis
or periarteriolar tissue damage.
Deep/subcortical WMC
The histopathological correlates of deep/subcortical white
matter changes are non-uniform. As can be derived from
Table 3, it is important to distinguish between the punctate
lesion type, and more widespread early confluent and
confluent changes. Punctate hyperintensities are commonly
of non-ischemic origin as their most common correlate is
widening of periarteriolar spaces [15, 20, 21, 50] accom-
panied by reduced myelination with atrophy of the neuropil
around fibrohyalinotic arteries (Fig. 3c, d). Early confluent
and confluent white matter hyperintensities are true ische-
mic lesions and represent a continuum of increasing tissue
damage, including widespread perivascular rarefaction of
myelin, mild to moderate fiber loss, and varying extents
of gliosis. Confluent changes are irregular, mostly rela-
tively well-demarcated areas of incomplete parenchymal
destruction with focal transitions to true infarcts.
Molecular pathology
In line with the previous reports [15, 20, 21, 50], the MRC-
CFAS also showed that periventricular lesion severity
was also associated with loss of ventricular ependyma,
while for deep/subcortical white matter lesions arteriolar
Table 2 Number and percentage of participants of the Austrian Stroke Prevention Study who showed progression of specific white matter lesion
types at 3-year and 6-year follow-up
Periventricular white matter lesionsa Deep white matter lesionsa
Caps/lining Halo Punctate Early confluent Confluent
Progression N/Nb (%) Progression N/Nb (%) Progression N/Nb (%) Progression N/Nb (%) Progression N/Nb (%)
3-year follow-up 55/241 (22.8) 9/38 (23.6) 9/233 (3.8) 17/59 (28.8) 19/35 (54.3)
6-year follow-up 54/132 (40.9) 6/8 (75.0) 19/128 (14.8) 10/16 (62.5) 10/11 (90.9)
The sample of subjects with 3-year and 6-year follow-up scans comprised of 468 and 232 community-dwelling individuals aged 47–87 years
a Lesion type refers to baseline MRI readings. Several subjects had more than one lesion type. For periventricular white matter lesions
progression was assessed as present or absent based on visual side by side comparison, for deep white matter lesions we defined presence of
progression as an increase in lesion volume beyond 1.81 cm3. This measure relates to the upper 95% limit of agreement from the most
pronounced difference between repeated measurements and is considered to represent the range of possible measurement error [60]
b Progression N/N = number of subjects with progression of specific lesion type/total number of subjects with this type of lesion at baseline
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Fig. 3 Correlation of in vivo
magnetic resonance imaging
(MRI) and histomorphological
features of affected fixed brains
in representative cases with
white matter lesions. a Caps
abutting upon the frontal horns
of the lateral ventricles, b Gross
overview of ventricle,
subventricular zone and partly
pale white matter (stain Luxol
fast blue), c multiple punctate
white matter hyperintensities in
the centrum semiovale
bilaterally, d enlarged cell-free
perivascular spaces in the
presence of vessel wall
hyalinosis. Luxol fast blue-
periodic acid–Schiff (PAS)-
stained whole mount section,
e early confluent and confluent
white matter lesions in the deep
and periventricular white matter
affecting both hemispheres,
f overview picture of severe
white matter changes with many
large and small white matter
lesions of variable shape
characterized by patchy myelin
loss with some cystic lacunar
lesions representing areas of
more severe tissue damage
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sclerosis was observed [24]. Importantly, the authors
reported that factors induced by hypoxia were elevated in
deep/subcortical lesions, but not in periventricular abnor-
malities. [24]. This supports a hypoxic etiology for deep
lesions and lends further evidence for periventricular white
matter changes being non-ischemic in etiology probably
caused by increased fluid accumulation related to the
proximity of the ventricles. Moreover, MRC-CFAS also
studied the astrocytic, microglial and oligodendroglial
responses in white matter abnormalities, and described that
both periventricular and deep/subcortical lesions are asso-
ciated with severe myelin loss and increased microglia
compared with non-lesional brain tissue [77]. Clasmato-
dendritic astroglia immunoreactive for fibrinogen were
more commonly present in periventricular lesions which
also showed more MAP-2 ?13 positive remyelinating
Table 3 Studies describing the histopathological correlates of different types of white matter lesions
Study Sample Histochemistry/
immunohistochemistry
MRI
[Tesla
(T)]
Fazekas
[20]
2 subjects without and 4
with neurologic
disease
HE, Masson’s trichrome, KB 1.5 Punctate lesions relate to perivascular damage with
fibrohyalinosis, atrophic neuropil and rarefaction of
myelinated fibers, 2 patients had cortical heterotopia
Chimowitz
[15]
7 subjects with
neurologic disease
KB, Congo red, desmine 1.5 Periventricular rims relate to ependymal loss and
subependymal gliosis
Periventricular caps relate to myelin pallor
Punctate DWMH are widened perivascular spaces
Fazekas
[21]
11 subjects partly with
neurologic disease
HE, Masson’s trichrome, KB 1.5 Periventricular rims: smooth myelin pallor, loose fibers,
tortuous venules, no arteriolosclerosis, discontinuity of
ependym with mild-moderate gliosis
Irregular periventricular lesions have varying fiber loss,
gliosis and cavitation with fibrohyalinosis
Deep white matter lesions: Punctate: no ischemic changes;
demyelination, atrophic neuropil around fibrohyalinotic
arterioles and perivenous damage
Early confluent: perivascular rarefaction of myelin, mild to
moderate fiber loss, varying gliosis
Confluent: irregular areas of incomplete parenchymal
destruction with focal transitions to true infarcts
Munoz [50] 2 Alzheimer cases and
13 controls
HE, chromoxane cyanine,
Bielschowsky, Congo red
1.5 Punctate relates to widened perivascular spaces
Extensive white matter lesions are broad areas of loss of
myelin, axons, and gliosis. No infarction or vascular wall
changes
Fernando
[24]
99 demented subjects
and 108 controls
CD68, Col IV, ICAM1,
HIF1alpha/2alpha, MMP7, Ngb,
NMBR, VEFGR2, betaA4
1.0 Vessel wall thickening, dilated perivascular spaces in
WMH, ependymal denudation in PVH. In WMH
microglial activation and upregulation of hypoxia factors
Simpson
[77]
Unselected tissue
blocks: 12 PVH, 12
DWMH, 15 NAWM
HE, LFB, MBP, GFAP, CD68,
PDGFalphaR, MAP-2(?13),
fibrinogen
1.0 More microglial activation in DWMH than in PVH.
Clasmatodendritic astrocytosis, positive for serum
proteins suggesting blood–brain barrier dysfunction.
Indicators for regeneration/remyelination in PVH
Simpson
[78]
Unselected tissue
blocks: 12 PVH, 12
DWMH, 15 NAWM
HLA-DR, B7-2, CD40, Mcm2,
PCNA, Ki67
1.0 PVH have more MHCII positive microglia and
costimulatory B7-2 and CD40, suggesting a more
proliferative/immune reactive environment. Amoeboid
microglia for phagocytosis of myelin breakdown
products in DWMH
B7-2 CD86, provides costimulatory signals necessary for T cell activation and survival, CD40 and CD40 ligand immune costimulatory
molecules, CD68 immunocytochemical marker for staining of monocytes/macrophages, Col IV collagen-IV, DWMH deep white matter hy-
perintensities, GFAP glial fibrilary acidic protein, HE hematoxylin–eosin, HIF hypoxia inducible factor, HLA-DR human leucocyte antigen-DR,
ICAM1 intercellular adhesion molecule, KB Kluvere–Barrera, LFB Luxol fast blue, MAP-2 ?13 microtubule associated protein 2 expressing
exon 13, MBP myelin basic protein, Mcm2 DNA replication licensing factor MCM2, MMP7 matrix metalloproteinase 7, NAWM normal-
appearing white matter, Ngb neuroglobin, NMBR neuromedin B receptor, PCNA and Ki67 molecules related to cell proliferation, PDGFalphaR
platelet-derived growth factor alpha receptor, PVH periventricular white matter hyperintensities, VEGFR2 vascular endothelial growth factor
receptor 2, WMH white matter hyperintensities
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oligodendrocytes and platelet-derived growth factor a
receptor-positive reactive astrocytes. The authors inter-
preted these findings as an indication for blood–brain
barrier dysfunction in a proportion of white matter lesions
and emphasize that attempts of remyelination appear to be
solely associated with periventricular white matter abnor-
malities [77]. The important role of the blood–brain barrier
in the pathogenesis of periventricular white matter changes
is also supported by the study’s finding that this lesion type
contains significantly higher levels of ramified activated
microglia which may result from blood–brain barrier dis-
ruption [77]. In contrast, activated microglia seen in deep/
subcortical abnormalities may rather reflect an innate
amoeboid phenotype, which is involved in phagocytosis of
myelin breakdown products [78].
Genetic aspects
Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leucoencephalopathy (CADASIL) is the most
common heritable cause of white matter lesions caused by
pathogenetic mutations that alter the number of cysteine
residues in the extracellular domain of NOTCH3.
NOTCH3 accumulates in small arteries of affected indi-
viduals [13]. These data and the estimated heritability
index of white matter lesions in the range of 55–73% [1,
12] led to the conduct of genetic association studies to
determine the role of genetic factors in the etiology of age-
related white matter changes. Previous epidemiologic
studies reported positive associations between the presence
of the apolipoprotein E (ApoE) e4 allele, and the extent and
progression of MRI lesions in the deep/subcortical white
matter [27, 88]. Our own group conducted a pilot study in
which we performed postmortem MRIs of unfixed brains in
13 patients who had died of various causes and used
immunohistochemistry to assess the presence of apoE
immunoreactivity in brain areas including white matter
lesions. ApoE immunoreactivity was observed in white
matter lesions, it appeared in astrocytes, in microglia and
also in neurons (Fig. 4). Quantification of ApoE expression
levels will be needed to better define the association
between ApoE and age-related white matter abnormalities.
Another important step will be to assess the influence of the
ApoE genotype on the expression level of the protein in
brain regions with and without white matter lesions.
Production or deposition of ApoE is hardly the cause of
but appears to associate with white matter lesions. Possi-
bly, ApoE plays a role in repair mechanisms for myelin.
The MRC-CFAS Study Group also provides important
information on pathways that may be involved in the
occurrence of age-related white matter changes [79]. These
authors extracted RNA to compare white matter lesions
with non-lesional white matter samples from cases with
white matter lesions and from cases with no lesions using
RNA microarray and pathway analysis. They identified 8
major pathways in which multiple genes showed altered
RNA transcription among 502 genes that were differen-
tially expressed in white matter lesions as compared to
non-lesional control tissue. The majority of differentially
regulated transcripts in white matter lesions coded for
genes associated with immune function, cell cycle, prote-
olysis, and ion transport. Changes were also observed in
pathways associated with electron transport, metabolism
and cell structure. The authors emphasize that the micro-
array approach is not able to discriminate the underlying
fundamental pathogenic insult from secondary changes in
cell function and pathophysiology [79]. The results repor-
ted by this investigation are therefore compatible with a
primary ischemic origin of white matter changes, but
increase the range of pathways in which target identifica-
tion for possible therapeutic intervention might be
considered. Genome-wide association studies are another
way to identify pathways involved in white matter lesion
development. The CHARGE Consortium [25] provided the
first meta-analysis of genome-wide association data from
9,361 individuals of European descent and identified novel
genetic associations with white matter hyperintensity bur-
den. Six SNPs mapping to a locus on chromosome 17q25
reached genome-wide significance, of which five were in
strong linkage disequilibrium (r2 [ 0.8). These SNPs
belong to a large cluster of associated SNPs spanning a
*100-kb region, which contains several genes: Two tri-
partite motif-containing genes, TRIM65 and TRIM47; the
WW domain binding protein 2 gene (WBP2); the mito-
chondrial ribosomal protein L38 gene (MRPL38); the Fas-
binding factor 1 gene (FBF1); and the acyl-coenzyme A
oxidase 1 gene (ACOX1). It is important that several of
these genes are related to the apoptosis superfamily and
apoptosis-related transcripts have also been shown to be
differentially expressed between white matter lesions and
normal white matter of brains in the MRC-CFAS [79].
Another mechanism that has been implicated in the etiol-
ogy of white matter lesions is increased production of
reactive oxygen species and again the MRC-CFAS pro-
vides some evidence for such a relationship by showing
that the hemochromatosis gene appears to be a genetic risk
factor for severe age-related white matter lesions inde-
pendently of the APOE e4 genotype. [26] It is of note in
this context that our own group has described evidence of
an association between low plasma concentrations of
vitamin E and a higher risk of cerebral white matter disease
in elderly subjects [66]. The relative importance of these
pathways for white matter lesion development and propa-
gation is yet unclear as is their relationship to different
white matter lesion types.
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Age-related white matter changes
and normal-appearing brain tissue
Recent advances in imaging techniques have highlighted
the importance of normal-appearing brain tissue in the
context of age-related white matter abnormalities. There is
more widespread tissue damage associated white matter
lesions which is not visible in conventional MR images, but
can be detected by new quantitative MR techniques, such
as diffusion tensor imaging (DTI) and magnetization
transfer imaging (MTI) [31, 47]. DTI provides information
about the microstructural integrity of brain tissue by mea-
suring the direction and magnitude of water diffusion in the
intracellular cytoplasm of the axons. Owing to the
restriction by lipid bilayers and other cell components,
water diffusion in brain tissue is anisotropic with the
highest diffusivity along the directions of the axons.
MTI is an approach to explore the composition of brain
tissue. Protons bound to larger molecules, such as the
myelin lipids and proteins have relaxation properties that
make them invisible for conventional MRI. However, the
pool of bound protons can be indirectly quantified by uti-
lizing magnetization transfer. MTI for mapping the
magnetization transfer ratio is readily available on most
clinical scanners and allows semi-quantitative assessment
of tissue changes with a higher image resolution than
Fig. 4 Postmortem MRI from non-fixed brains and immunohisto-
chemical staining for APO-E. a postmortem MRI shows only mild
white matter hyperintensity in the vicinity of the posterior horn of the
lateral ventricle (arrow), b punctate white matter changes in the
subcortical white matter (arrow), c severe patchy confluent white
matter damage in deep/subcortical white matter at supraventricular
level (arrow), d–i Micrographs showing an overview of apoE
expression in representative cases in vessel walls, astrocytes and
oligodendrocytes in white matter containing MRI white matter
hyperintensities and in micrographs highlighting blood vessels with
different expression intensities, d Immunohistochemical staining at
low magnification showing ApoE-positive staining in multiple
astrocytes and in the area of a blood vessel (arrow head), e, f Apo-
E positively stained vessel wall (arrow heads) and astrocytes
(arrows), g Apo-E weakly h moderately, and i strongly stained
vessel walls
Acta Neuropathol (2011) 122:171–185 179
123
T
a
b
le
4
C
o
m
p
o
si
te
o
f
st
u
d
ie
s
o
n
h
is
to
p
at
h
o
lo
g
ic
al
an
d
cl
in
ic
al
co
rr
el
at
es
o
f
d
if
fu
si
o
n
te
n
so
r
an
d
m
ag
n
et
iz
at
io
n
tr
an
sf
er
im
ag
in
g
(D
T
I
an
d
M
T
I)
m
et
ri
cs
in
ex
v
iv
o
an
d
in
v
iv
o
m
o
d
el
s
S
tu
d
y
T
is
su
e
ty
p
e
C
o
h
o
rt
(N
)
B
ra
in
re
g
io
n
M
ea
su
re
(p
ar
am
et
er
s)
F
in
d
in
g
s
A
n
im
al
m
o
d
el
H
o
ll
an
d
et
al
.
[3
6
]
W
M
M
ic
e
4
W
M
tr
ac
ts
D
T
I
(F
A
)/
M
IT
(M
T
R
)
F
A
an
d
M
T
R
co
rr
el
at
e
w
it
h
m
ar
k
er
s
o
f
m
y
el
in
in
te
g
ri
ty
/d
eg
ra
d
at
io
n
S
h
er
ee
n
et
al
.
[7
6
]
W
M
M
ic
e
F
im
b
ri
a,
in
te
rn
al
?
ex
te
rn
al
ca
p
su
le
D
T
I
(F
A
)
D
T
I
p
ar
am
et
er
s
ar
e
se
n
si
ti
v
e
to
ax
o
n
al
an
d
d
en
d
ri
ti
c
in
ju
ry
in
ac
u
te
is
ch
em
ic
st
ro
k
e
P
o
st
m
o
rt
em
st
u
d
ie
s
S
ch
m
ie
re
r
et
al
.
[7
3
]
P
o
st
m
o
rt
em
—
W
M
M
S
(1
6
)
O
n
e
sl
ic
e
D
T
I
(F
A
,
M
D
)
In
cr
ea
se
in
M
D
an
d
d
ec
re
as
e
in
F
A
o
f
W
M
L
s
an
d
/o
r
N
A
W
M
in
d
ic
at
e
th
e
p
re
se
n
ce
o
f
ax
o
n
al
lo
ss
S
ch
m
ie
re
r
et
al
.
[7
2
]
P
o
st
m
o
rt
em
—
N
A
W
M
M
S
(2
0
)
S
li
ce
s
(t
h
ic
k
n
es
s
1
cm
)
M
T
I
(M
T
R
)
M
T
R
p
ar
am
et
er
as
p
re
d
ic
to
rs
o
f
m
y
el
in
co
n
te
n
t;
M
T
R
d
if
fe
rs
b
et
w
ee
n
W
M
L
an
d
N
A
W
M
S
ch
m
ie
re
r
et
al
.
[7
1
]
P
o
st
m
o
rt
em
—
W
M
M
S
(2
0
)
S
li
ce
s
(t
h
ic
k
n
es
s
1
cm
)
M
T
I
(M
T
R
)
N
eg
.
co
rr
el
at
io
n
b
et
w
ee
n
m
y
el
in
co
n
te
n
t
an
d
M
T
R
;
M
T
R
is
af
fe
ct
ed
b
y
m
y
el
in
co
n
te
n
t
in
M
S
W
M
G
o
u
w
et
al
.
[2
9
]
P
o
st
m
o
rt
em
—
N
A
W
M
an
d
W
M
H
A
D
(3
3
)
v
er
su
s
H
C
(7
)
1
0
4
R
O
Is
in
W
M
H
an
d
N
A
W
M
D
T
I
(A
D
C
,
F
A
),
F
L
A
IR
(T
1
-
re
la
x
.)
Q
u
an
ti
ta
ti
v
e
M
R
te
ch
n
iq
u
es
re
v
ea
l
d
if
fe
re
n
ce
s
in
W
M
H
b
et
w
ee
n
A
D
an
d
n
o
n
-
d
em
en
te
d
el
d
er
ly
an
d
ar
e
ab
le
to
re
fl
ec
t
th
e
se
v
er
it
y
o
f
n
eu
ro
p
at
h
o
lo
g
ic
al
ch
an
g
es
In
v
iv
o
st
u
d
ie
s
C
h
ab
ri
at
et
al
.
[1
4
]
W
M
H
v
er
su
s
W
M
C
A
D
A
S
IL
(1
6
)
v
er
su
s
H
C
(1
0
)
F
o
u
r
sl
ic
es
at
th
e
le
v
el
o
f
ce
n
tr
u
m
se
m
io
v
al
e
D
T
I
(F
A
,
M
D
)
M
ic
ro
st
ru
ct
u
ra
l
ch
an
g
es
ar
e
re
la
te
d
to
se
v
er
it
y
o
f
th
e
cl
in
ic
al
st
at
u
s;
D
T
I
p
ar
am
et
er
s
ar
e
se
n
si
ti
v
e
to
ch
an
g
es
in
W
M
L
an
d
N
A
W
M
T
an
ab
e
et
al
.
[8
4
]
W
M
H
S
IV
D
(1
5
)
v
er
su
s
H
C
(1
6
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
M
T
I
(M
T
R
)
M
T
R
o
f
P
V
W
M
H
w
as
lo
w
er
in
S
IV
D
th
an
in
co
n
tr
o
ls
;
p
at
h
o
lo
g
ic
ch
an
g
es
in
V
D
ar
e
m
o
st
se
v
er
e
in
P
V
W
M
S
ch
m
ie
re
r
et
al
.
[7
0
]
N
A
B
T
P
P
-M
S
(1
5
)
v
er
su
s
H
C
(6
)
1
0
R
O
Is
(N
A
-t
h
al
am
u
s
an
d
N
A
W
M
)
D
T
I
(A
D
C
av
)
In
cr
ea
se
o
f
A
D
C
in
P
P
M
S
o
v
er
1
y
ea
r
in
N
A
W
M
;
th
is
co
rr
el
at
es
w
it
h
in
cr
ea
se
s
in
le
si
o
n
v
o
lu
m
e;
N
A
W
M
m
ea
su
re
d
w
it
h
D
T
I
is
cl
in
ic
al
ly
re
le
v
an
t
O
’S
u
ll
iv
an
et
al
.
[5
2
]
W
M
d
am
ag
e
IL
(3
6
)
v
er
su
s
H
C
(1
9
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
D
T
I/
cM
R
I
In
cr
ea
se
d
d
if
fu
si
v
it
y
in
W
M
le
si
o
n
s
an
d
N
A
W
M
;
M
D
o
f
N
A
W
M
co
rr
el
at
ed
w
it
h
IQ
an
d
ex
ec
u
ti
v
e
fu
n
ct
io
n
F
az
ek
as
et
al
.
[2
2
]
N
A
B
T
H
ea
lt
h
y
el
d
er
ly
(1
9
8
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
M
T
I
(M
T
R
)
M
T
R
d
ec
re
as
ed
si
g
n
ifi
ca
n
tl
y
w
it
h
in
cr
ea
si
n
g
sc
o
re
s
o
f
W
M
H
se
v
er
it
y
an
d
W
M
H
v
o
lu
m
e;
M
T
R
ca
n
se
rv
e
to
q
u
an
ti
fy
W
M
H
-a
ss
o
ci
at
ed
ti
ss
u
e
d
am
ag
e
S
p
il
t
et
al
.
[8
1
]
N
A
W
M
,
W
M
(H
)
Y
o
u
n
g
(1
1
),
m
in
im
al
W
M
H
(5
1
),
ab
u
n
d
an
t
W
M
H
(4
1
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
M
T
I
(M
T
R
)
M
T
R
d
ec
re
as
es
w
it
h
ag
e
an
d
W
M
H
in
cr
ea
se
;
ag
e
g
iv
es
ri
se
to
ch
an
g
es
in
N
A
B
T
;
th
es
e
ch
an
g
es
se
em
to
h
av
e
a
re
la
ti
o
n
sh
ip
w
it
h
ag
e-
re
la
te
d
W
M
H
an
d
m
ig
h
t
h
av
e
d
if
fe
re
n
t
et
io
lo
g
y
S
p
il
t
et
al
.
[8
2
]
P
er
iv
en
tr
ic
u
la
r
W
M
H
v
er
su
s
d
ee
p
W
M
H
W
M
H
(5
6
)
v
er
su
s
m
il
d
/n
o
W
M
H
(1
9
)
P
er
iv
en
tr
ic
u
la
r
W
M
H
an
d
d
ee
p
W
M
H
M
T
I
(M
T
R
)
M
ea
n
M
T
R
o
f
P
V
W
M
H
w
as
lo
w
er
th
an
D
W
M
H
;
ag
e-
re
la
te
d
W
M
H
ar
e
h
et
er
o
g
en
eo
u
s
d
es
p
it
e
si
m
il
ar
ap
p
ea
ra
n
ce
o
n
T
2
-w
ei
g
h
te
d
im
ag
es
B
en
ed
et
ti
et
al
.
[8
]
W
M
,
G
M
H
C
(8
9
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
D
T
I
(M
D
)/
M
T
I
(M
T
R
)
N
o
rm
al
iz
ed
b
ra
in
,
G
M
an
d
W
M
an
d
th
e
n
u
m
b
er
o
f
T
2
-h
y
p
er
in
te
n
si
ti
es
co
rr
el
at
e
w
it
h
ag
e;
G
M
av
er
ag
e
M
D
an
d
G
M
v
o
lu
m
e
ar
e
in
d
ep
en
d
en
t
p
re
d
ic
to
rs
o
f
su
b
je
ct
’s
ag
e;
N
it
k
u
n
an
et
al
.
[5
1
]
A
sy
m
p
to
ti
c
W
M
H
to
sy
m
p
to
m
at
ic
ce
re
b
ra
l
S
V
D
S
V
D
(2
9
)
v
er
su
s
h
i-
su
b
je
ct
s
(6
3
)
v
er
su
s
H
C
(4
2
)
C
en
tr
u
m
se
m
io
v
al
e
W
M
D
T
I
(M
D
)/
M
R
S
D
T
I
co
rr
el
at
ed
w
it
h
N
A
A
(n
eg
.)
—
d
ep
en
d
in
g
o
n
se
v
er
it
y
o
f
d
is
ea
se
;
N
A
A
is
a
m
ar
k
er
fo
r
ax
o
n
al
lo
ss
/d
y
sf
u
n
ct
io
n
180 Acta Neuropathol (2011) 122:171–185
123
T
a
b
le
4
co
n
ti
n
u
ed
S
tu
d
y
T
is
su
e
ty
p
e
C
o
h
o
rt
(N
)
B
ra
in
re
g
io
n
M
ea
su
re
(p
ar
am
et
er
s)
F
in
d
in
g
s
B
as
ti
n
et
al
.
[7
]
N
A
W
M
v
er
su
s
P
V
W
M
H
E
ld
er
ly
(4
2
)
N
A
W
M
v
er
su
s
P
V
W
M
H
D
T
I
(F
A
,
M
D
)/
M
T
I
(M
T
R
)
P
V
W
M
H
h
ad
g
re
at
er
M
D
th
an
N
A
W
M
;
F
A
an
d
M
T
R
w
er
e
si
g
n
ifi
ca
n
tl
y
re
d
u
ce
d
in
P
V
W
M
H
co
m
p
ar
ed
to
N
A
W
M
;
P
V
W
M
H
M
T
R
co
rr
el
at
ed
w
it
h
M
D
an
d
F
A
L
ee
et
al
.
[4
3
]
N
A
W
M
an
d
W
M
H
in
A
D
,
M
C
I
an
d
H
C
A
D
(4
7
)/
M
C
I
(7
3
)/
H
C
(9
5
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
D
T
I
(F
A
)
A
D
h
ad
lo
w
er
F
A
th
an
H
C
o
r
M
C
I
in
re
g
io
n
s
w
it
h
h
ig
h
er
b
as
el
in
e
an
is
o
tr
o
p
y
;
F
A
in
W
M
H
w
as
lo
w
er
th
an
in
N
A
W
M
B
h
ad
el
ia
et
al
.
[9
]
W
M
in
cc
(g
ai
t-
im
p
ai
re
d
)
el
d
er
ly
(1
7
3
)
cc
(F
A
in
g
en
u
an
d
sp
le
n
iu
m
)
D
T
I
(F
A
)
P
at
ie
n
ts
w
it
h
ab
n
o
rm
al
g
ai
t
h
ad
lo
w
F
A
in
th
e
g
en
u
,
b
u
t
n
o
t
in
sp
le
n
iu
m
;
W
M
in
te
g
ri
ty
o
f
th
e
g
en
u
is
an
im
p
o
rt
an
t
m
ar
k
er
o
f
g
ai
t
in
th
e
el
d
er
ly
R
o
p
el
e
et
al
.
[6
0
]
N
A
B
T
an
d
w
it
h
in
W
M
H
E
ld
er
ly
(3
4
0
D
W
I/
1
7
7
M
T
R
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
D
W
I
(A
D
C
)/
M
IT
(M
T
R
)
W
M
H
se
v
er
it
y
an
d
ag
e
ar
e
si
g
n
ifi
ca
n
t
p
re
d
ic
to
rs
o
f
g
lo
b
al
A
D
C
an
d
M
T
R
ch
an
g
es
;
A
D
C
an
d
M
T
R
ar
e
se
n
si
ti
v
e
fo
r
ag
e
an
d
W
M
H
-r
el
at
ed
ch
an
g
es
in
N
A
B
T
S
ch
m
id
t
et
al
.
[6
9
]
N
A
B
T
E
ld
er
ly
(3
4
0
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
D
W
I
(A
D
C
)
In
cr
ea
se
d
W
M
H
co
rr
el
at
ed
w
it
h
h
ig
h
er
fr
eq
u
en
cy
o
f
h
y
p
er
te
n
si
o
n
,
a
g
re
at
er
W
M
H
v
o
lu
m
e,
m
o
re
b
ra
in
at
ro
p
h
y
,
w
o
rs
e
o
v
er
al
l
co
g
n
it
iv
e
p
er
fo
rm
an
ce
an
d
ch
an
g
es
in
A
D
C
W
an
g
et
al
.
[9
3
]
W
M
H
s
an
d
W
M
ch
an
g
es
A
D
w
it
h
m
il
d
W
M
H
(1
5
),
se
v
er
e
W
M
H
(1
2
),
H
C
w
it
h
m
il
d
W
M
H
(1
7
)
R
O
I-
b
as
ed
D
T
I
(F
A
,
M
D
,
D
(R
),
D
(A
)
F
A
an
d
D
(R
)
w
er
e
m
o
re
se
n
si
ti
v
e
th
an
M
D
an
d
D
(A
)
in
d
if
fe
re
n
ti
at
in
g
A
D
fr
o
m
co
n
tr
o
ls
,
M
D
w
as
m
o
re
se
n
si
ti
v
e
in
d
is
ti
n
g
u
is
h
in
g
A
D
w
it
h
se
v
er
e
W
M
H
s
fr
o
m
th
o
se
w
it
h
m
il
d
W
M
H
s.
R
o
sa
n
o
et
al
.
[6
1
]
W
M
,
W
M
H
(g
ai
t-
im
p
ai
re
d
)
el
d
er
ly
(7
9
5
)
W
h
o
le
b
ra
in
(g
lo
b
al
)
M
T
I
(M
T
R
)
W
o
m
en
h
ad
lo
w
er
M
T
R
,
h
ig
h
er
W
M
H
an
d
b
ra
in
at
ro
p
h
y
(B
A
),
b
u
t
n
o
t
b
ra
in
in
fa
rc
ts
(B
I)
,
re
m
ai
n
ed
as
so
ci
at
ed
w
it
h
sl
o
w
er
g
ai
t;
in
m
en
W
M
H
an
d
B
A
,
b
u
t
n
o
t
M
T
R
o
r
B
I,
re
m
ai
n
ed
as
so
ci
at
ed
w
it
h
sl
o
w
er
g
ai
t
A
D
A
lz
h
ei
m
er
’s
d
is
ea
se
,
A
D
C
ap
p
ar
en
t
d
if
fu
si
o
n
co
ef
fi
ci
en
t,
C
A
D
A
S
IL
ce
re
b
ra
l
au
to
so
m
al
d
o
m
in
an
t
ar
te
ri
o
p
at
h
y
w
it
h
su
b
co
rt
ic
al
in
fa
rc
ts
an
d
le
u
k
o
en
ce
p
h
al
o
p
at
h
y
,
cc
co
rp
u
s
ca
ll
o
su
m
,
D
(A
)
ax
ia
l
d
if
fu
si
v
it
y
,
D
(R
)
ra
d
ia
l
d
if
fu
si
v
it
y
,
D
T
I
d
if
fu
si
o
n
te
n
so
r
im
ag
in
g
,
D
W
I
d
if
fu
si
o
n
w
ei
g
h
te
d
im
ag
in
g
,
F
A
fr
ac
ti
o
n
al
an
is
o
tr
o
p
y
,
G
M
g
ra
y
m
at
te
r,
H
C
h
ea
lt
h
y
co
n
tr
o
ls
,
IL
is
ch
em
ic
le
u
k
o
ar
ai
o
si
s,
M
C
I
m
il
d
co
g
n
it
iv
e
im
p
ai
rm
en
t,
M
D
m
ea
n
d
if
fu
si
v
it
y
,
M
R
S
m
ag
n
et
ic
re
so
n
an
ce
sp
ec
tr
o
sc
o
p
y
,
M
S
m
u
lt
ip
le
sc
le
ro
si
s,
M
T
I
m
ag
n
et
iz
at
io
n
tr
an
sf
er
im
ag
in
g
,
M
T
R
m
ag
n
et
iz
at
io
n
tr
an
sf
er
ra
ti
o
,
N
A
A
N
-a
ce
ty
l
as
p
ar
ta
te
,
N
A
B
T
n
o
rm
al
-a
p
p
ea
ri
n
g
b
ra
in
ti
ss
u
e,
N
A
W
M
n
o
rm
al
-a
p
p
ea
ri
n
g
w
h
it
e
m
at
te
r,
P
V
W
M
H
p
er
iv
en
tr
ic
u
la
r
w
h
it
e
m
at
te
r
h
y
p
er
in
te
n
si
ti
es
,
R
O
I
re
g
io
n
o
f
in
te
re
st
,
S
IV
D
su
b
co
rt
ic
al
is
ch
em
ic
v
as
cu
la
r
d
em
en
ti
a,
S
V
D
sm
al
l
v
es
se
l
d
is
ea
se
,
W
M
(L
)
w
h
it
e
m
at
te
r
(l
es
io
n
),
W
M
H
w
h
it
e
m
at
te
r
h
y
p
er
in
te
n
si
ti
es
Acta Neuropathol (2011) 122:171–185 181
123
provided by DTI [34, 48, 49]. Table 4 describes the results
of DTI and MTI in various settings and disease entities.
Animal models and postmortem studies indicate that
increased fractional anisotropy and mean diffusivity
derived from DTI and magnetization transfer ratio from
MTI correlate with axonal loss, demyelination and dentritic
injury [29, 36, 70, 76]. A recent study in hypoperfused
mice is of particular interest as it examined the comple-
mentary value of DTI and MTI measures for delineation of
white matter damage [36]. The authors showed that an
experimental comparison between quantitative MRI and
pathology is possible even in small animals like mice.
Moreover, they reported that a reduction in fractional
anisotropy is paralleled by a decrease in the magnetiza-
tion transfer ratio in several tissue compartments after
continuous moderate hypoperfusion over 1 month. They
concluded that both techniques are sufficiently suited to
detect microstructural tissue alterations at least in the white
matter of the murine brain. Postmortem histological anal-
yses assessing myelin content, axonal density, and gliosis
revealed similar correlations in brains of patients with
Alzheimer’s disease [29] or multiple sclerosis [71–73].
As can also be seen from Table 4 in vivo studies in
humans consistently reported that mean diffusivity and
fractional anisotropy, and in most investigations also
magnetization transfer ratios, are more affected in age-
related white matter lesions than in normal-appearing white
matter [7, 22, 43, 59, 69, 72, 81]. There existed a signifi-
cant association between white matter lesion load and
severity of DTI and MTR measures in the normal-
appearing white matter with the microstructural changes in
normal brain tissue being more closely related to the
patients’ clinical presentation than the volume of visible
white matter abnormalities [9, 32, 52, 61, 69, 70, 74, 92,
93]. These observations clearly indicate that age-related
small vessel disease of the brain is a diffuse process
affecting the entire brain and that white matter lesions are
probably only the tip of the iceberg. Similar data come
from the application of DTI in CADASIL. These studies
also show an increase in diffusivity, which is better cor-
related with severity of executive dysfunction and clinical
disability than are T2 hyperintensities [14].
So far, there exists only little information as to whether
different types of age-related white matter changes are
accompanied by different microstructural tissue changes.
One study reported the mean magnetization ratio in peri-
ventricular white matter hyperintensities to be lower than
in deep white matter abnormalities, and the mean magne-
tization ratio in frontal periventricular changes to be lower
than in occipital periventricular changes [82]. Further
studies on possible differences in accompanying tissue
destruction between different white matter lesion types
are needed, as their results are likely to improve our
understanding of the differential clinical effects of white
matter abnormalities occurring in aging individuals. Met-
rics derived from these novel quantitative MRI techniques
will not only help in understanding the microstructural
tissue changes associated with cerebral small vessel disease
in white matter, but also in other affected tissue compart-
ments, such as the cortex. Based on the association
between white matter alterations and neurodegenerative
diseases at least in patients with neurodegenerative disor-
ders one possible explanation for white matter changes
could be Wallerian degeneration as a consequence of cor-
tical neuron loss [94]. Moreover, one very recent study has
shown that postmortem high-resolution MRI is able to
detect intracortical infarcts in CADASIL and possibly also
in other small vessel diseases of the brain [42]. In this
study, MRI was used to guide the neuropathological
examination of the cortex. Just as in this case, future
studies will have to be supplemented by postmortem cor-
relations in samples of normal-appearing brain tissue on
standard MRI that have also been scanned by modern
imaging techniques like DTI and MTI prior to the histo-
pathological examination. However, it is important to
realize that pathohistological correlations with new quan-
titative MRI techniques have to be done preferentially by
the use of fresh brain tissue as formalin fixation influences
tissue proton relaxation characteristics.
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